I take Vyvanse (lisdexamfetamine) 40 mg daily for ADHD, and after a one‑week drug holiday my daytime sleepiness worsened; should I continue the medication and undergo a sleep evaluation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Continue Vyvanse and Pursue Sleep Evaluation

You should continue taking Vyvanse 40 mg daily and undergo a comprehensive sleep evaluation, as your worsening tiredness during the drug holiday suggests the medication is actually helping manage an underlying sleep-related symptom rather than causing it. 1

Why the Drug Holiday Made Things Worse

Your experience of worsened daytime sleepiness during the one-week Vyvanse holiday is clinically significant and reveals important information:

  • Stimulants like lisdexamfetamine (Vyvanse) can paradoxically improve sleep-related symptoms in ADHD patients by treating the underlying disorder that contributes to poor sleep quality and daytime dysfunction 2, 3

  • When you stopped the medication, your untreated ADHD symptoms likely returned, leading to:

    • Poorer sleep quality at night (even if you slept longer)
    • More daytime sleepiness due to unmanaged ADHD
    • Possible rebound fatigue from medication discontinuation 4
  • The FDA label for Vyvanse notes that withdrawal symptoms after discontinuation include fatigue, hypersomnia, and dysphoric mood 4, which aligns with your experience

The Sleep-ADHD Connection You Need to Investigate

The guidelines emphasize that excessive daytime sleepiness in patients taking stimulants requires evaluation for underlying sleep disorders, not automatic medication discontinuation 1. Here's what needs assessment:

Primary Sleep Disorders to Rule Out:

  • Obstructive sleep apnea (OSA) - requires polysomnography
  • Periodic limb movement disorder
  • Restless legs syndrome
  • Narcolepsy or idiopathic hypersomnia (less likely but possible)
  • Circadian rhythm disorders 1, 3

Key Clinical Point:

"In patients with drug- or medication-induced sedation, the treatment is to reduce or remove the drug or substance. This therapy should preferably be instituted under the guidance of both a sleep specialist, who is familiar with these drugs, and the patient's primary care physician" 1. However, your case is the opposite - you had worsening sedation when the drug was removed, suggesting the medication is therapeutic, not causative.

Recommended Evaluation Algorithm

Step 1: Sleep Specialist Referral

  • Polysomnography (overnight sleep study) to assess:
    • Sleep architecture and efficiency
    • Presence of sleep-disordered breathing
    • Limb movements during sleep
    • Sleep onset latency and total sleep time 1

Step 2: Clinical Assessment While Continuing Vyvanse

  • Epworth Sleepiness Scale to quantify daytime sleepiness 5
  • Sleep diary for 2 weeks documenting:
    • Bedtime and wake time
    • Sleep onset latency
    • Number of awakenings
    • Daytime naps
    • Vyvanse timing relative to sleep 6

Step 3: Optimize Sleep Hygiene (While Maintaining Medication)

  • Regular sleep-wake schedule with adequate nocturnal sleep opportunity
  • Avoid heavy meals and alcohol
  • Consider scheduled 15-20 minute naps (around noon and 4-5 PM if needed) 1
  • Ensure Vyvanse is taken early in the day (upon awakening) 4

Why Not to Stop Vyvanse

Multiple lines of evidence support continuing your medication:

  1. Research shows stimulants generally do not cause clinically significant sleep problems in most patients - one study of lisdexamfetamine found "no statistically significant increase in latency to persistent sleep" and concluded it "did not appear to contribute to any sleep disturbances" 7

  2. Your personal trial demonstrated worsening symptoms off medication - this is the most important evidence. The 2024 guideline notes that "the consensus is that the magnitude of documented risks is very low and that treatment with medications should not be stopped if they are required for the daily functioning" 8

  3. Drug holidays are primarily useful for managing side effects that are actually present 9, 10. Since your tiredness worsened rather than improved, this suggests the medication is not the cause

  4. Untreated ADHD itself is strongly associated with sleep problems including "bedtime resistance, difficulty with morning awakenings, sleep onset difficulties, night awakenings and daytime sleepiness" 3

Common Pitfall to Avoid

Do not assume that because you take a stimulant and feel tired, the stimulant is causing the tiredness. This is a frequent clinical error. The relationship between ADHD, stimulant medications, and sleep is "complex and multidirectional" 3. Your worsening symptoms during the drug holiday strongly suggest:

  • Either ADHD itself is contributing to poor sleep quality
  • Or you have a comorbid sleep disorder that needs separate treatment
  • Or the stimulant was actually helping manage daytime symptoms that masked an underlying problem

Monitoring Going Forward

While continuing Vyvanse and awaiting sleep evaluation:

  • Monitor for cardiovascular effects (blood pressure, heart rate) as required by FDA labeling 4
  • Track your sleep patterns objectively with a sleep diary
  • Note any new or worsening symptoms including anxiety, irritability, or appetite changes 4, 11
  • Ensure adequate nutrition and hydration as decreased appetite is common (62.4% incidence) 11

The 2009 guideline emphasizes that "frequent reassessment of impairments in functional ability due to residual sleepiness is necessary" and that patients should be referred to a sleep specialist "when the cause of sleepiness is unknown" 1. Your case clearly warrants this referral while maintaining your effective ADHD treatment.

References

Research

Attention Deficit Hyperactivity Disorder Medications and Sleep.

Child and adolescent psychiatric clinics of North America, 2022

Research

Associations of sleep disturbance with ADHD: implications for treatment.

Attention deficit and hyperactivity disorders, 2015

Guideline

palliative care version 1.2016.

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

Research

Examining daily stimulant medication use and sleep in adolescents with ADHD.

European child & adolescent psychiatry, 2024

Guideline

attention-deficit/hyperactivity disorder in pregnancy and the postpartum period.

American Journal of Obstetrics and Gynecology, 2024

Research

Weekend holidays during methylphenidate use in ADHD children: a randomized clinical trial.

Journal of child and adolescent psychopharmacology, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.